{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-021707","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2026-06-25T20:31:27+00:00","discovered_at":"2026-06-25T20:32:01.426096+00:00","generated_at":"2026-06-25T20:32:17.246223+00:00","sec_items":["1.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"AYTU terminates Metadate CD license agreement with Lannett","bullets":["Mutual termination effective June 23, 2026; certain provisions survive per Termination Agreement.","AYTU may continue to sell existing inventory and pay royalties until sales cease.","Metadate CD net revenue for quarter ended March 31, 2026 was $49,000, de minimis.","Termination Agreement will be filed as exhibit to FY 2026 10-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-021707","json":"https://secwatch.observer/filing/0001437749-26-021707.json","markdown":"https://secwatch.observer/filing/0001437749-26-021707.md","text":"https://secwatch.observer/filing/0001437749-26-021707.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/0001437749-26-021707-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926021707/aytu20260624c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T20:32:17.246223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}